SFX by Ex Libris Inc.

Title:	Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II
Source:	Science [0036-8075] Schneider, T yr:2010

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Saporta, I. "Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus." Nature 437.7061 (2005): 975-980.
description	2.	Hancock, Robert E. "Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies." Nature biotechnology 24.12 (2006): 1551-7.
description	3.	Taylor, K., Clarke, D. J., McCullough, B., Chin, W, K. "Analysis and Separation of Residues Important for the Chemoattractant and Antimicrobial Activities of {beta}-Defensin 3." The Journal of biological chemistry 283.11 (2008): 6631-6639.
description	4.	Pfaller MA, Sheehan DJ, Rex JH, J H A. "Determination of fungicidal activities against yeasts and molds: lessons learned from bactericidal testing and the need for standardization." Clinical microbiology reviews 17.2: 268-80.
description	5.	Reddy, K.V.R. R. "Antimicrobial peptides: premises and promises." International Journal of Antimicrobial Agents 24.6 (2004): 536-547.
description	6.	Zasloff, M. "Antimicrobial peptides of multicellular organisms." Nature 415.6870 (2002): 389-395.
description	7.	Yeaman, Michael R. "Mechanisms of antimicrobial peptide action and resistance." Pharmacological reviews 55.1 (2003): 27-55.
description	8.	Toke, O. "Antimicrobial peptides: New candidates in the fight against bacterial infections." Biopolymers 80.6 (2005): 717-735.
description	9.	Zasloff, M. "Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream." Clinical infectious diseases 47.12 (2009): 1537-45.
description	10.	Hancock, R E W. "Cationic peptides: a new source of antibiotics." Trends in biotechnology 16.2 (1998): 82-88.
description	11.	Peschel, A. "The co-evolution of host cationic antimicrobial peptides and microbial resistance." Nature reviews. Microbiology 4.7 (2006): 529-536.
description	12.	Schneider, Christopher D. "Designing antimicrobial peptides: form follows function." Nature reviews. Drug discovery 11.1 (2012): 37-51.
description	13.	Marr, A.K. K. "Antibacterial peptides for therapeutic use: obstacles and realistic outlook." Current opinion in pharmacology 6.5 (2006): 468-472.
description	14.	Scaloni, A. "Structure, conformation and biological activity of a novel lipodepsipeptide from Pseudomonas corrugata: cormycin A." The Biochemical journal 384.1 (2004): 25-36.
description	15.	Sorensen, Mark V. "Neandertal energetics and foraging efficiency." Journal of human evolution 40.6 (2001): 483-495.
description	16.	Rollins-Smith Louise A, L.A. A. "Antimicrobial peptide defenses against pathogens associated with global amphibian declines." Developmental and comparative immunology 26.1 (2002): 63-72.
description	17.	Amblard, M. "Methods and protocols of modern solid phase peptide synthesis." Molecular Biotechnology 33.3 (2006): 239-254.
description	18.	Yeo, S. "Current status of nonculture methods for diagnosis of invasive fungal infections." Clinical microbiology reviews 15.3 (2002): 465-484.
description	19.	Roehrl, J. "Identification and biological characterization of mouse beta-defensin 14, the orthologue of human beta-defensin 3." The Journal of biological chemistry 283.9 (2007): 5414-5419.
description	20.	Pianowski, Zbigniew L L. "Fluorescence-based detection of single nucleotide permutation in DNA via catalytically templated reaction." Chemical communications 2007.37 (2007): 3820-2.